Literature DB >> 20593380

p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

L Ricks-Santi1, T Mason, V Apprey, C Ahaghotu, A McLauchlin, D Josey, G Bonney, G M Dunston.   

Abstract

BACKGROUND: p53 is a transcription factor that regulates the cell cycle, DNA repair, and apoptosis. A variant at codon 72, rs1042522, results in altered activities for p53 and is, notably, differentially distributed among different ethnic populations. However, associations of this variant with cancer in men of African descent have not been explored. Herein, we tested the hypothesis that rs1042522 was associated with prostate cancer (PCa) risk.
MATERIALS AND METHODS: Genotypes were determined by PCR-RFLP methods in a study population of African descent consisting of 266 PCa patients and 196 male controls.
RESULTS: Our results indicate that the p53 polymorphism may be associated with increased risk of PCa. Genotypes were significantly and marginally associated with PCa risk using the dominant and log-additive genetic models (OR=1.53, 95% CI: 1.02-2.29, P=0.04; OR=1.33, 95% CI: 0.99-1.78, P=0.06, respectively). After adjusting for age, the associations with PCa remained, but results were not statistically significant (OR=1.48, 95% CI: 0.95-2.31, P=0.08; OR=1.30, 95% CI: 0.95-1.80, P=0.10, respectively).
CONCLUSIONS: The present study demonstrates that population-dependent differences in allele frequencies associated with health disparities provide a valuable framework for the interrogation of complex diseases in all populations.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593380      PMCID: PMC3057117          DOI: 10.1002/pros.21209

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  61 in total

1.  Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Authors:  David P Miller; Geoffrey Liu; Immaculata De Vivo; Thomas J Lynch; John C Wain; Li Su; David C Christiani
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

Review 2.  TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.

Authors:  A Matakidou; T Eisen; R S Houlston
Journal:  Mutagenesis       Date:  2003-07       Impact factor: 3.000

Review 3.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

4.  Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.

Authors:  G Liu; D P Miller; W Zhou; S W Thurston; R Fan; L L Xu; T J Lynch; J C Wain; L Su; D C Christiani
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

5.  Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.

Authors:  Johanna Tommiska; Hannaleena Eerola; Mira Heinonen; Laura Salonen; Milja Kaare; Jonna Tallila; Ari Ristimäki; Karl von Smitten; Kristiina Aittomäki; Päivi Heikkilä; Carl Blomqvist; Heli Nevanlinna
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

6.  P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans.

Authors:  R J Pegoraro; M Moodley; L Rom; R Chetty; J Moodley
Journal:  Int J Gynecol Cancer       Date:  2003 Jul-Aug       Impact factor: 3.437

7.  P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.

Authors:  R J Pegoraro; L Rom; P A Lanning; M Moodley; S Naiker; J Moodley
Journal:  Int J Gynecol Cancer       Date:  2002 Jul-Aug       Impact factor: 3.437

8.  A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese.

Authors:  Kazuhiro Suzuki; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Tomoyuki Takei; Haruki Nakazato; Hironobu Okugi; Hidekazu Koike; Yoshihiro Ono; Kazuto Ito; Kohei Kurokawa; Hidetoshi Yamanaka
Journal:  J Biomed Sci       Date:  2003 Jul-Aug       Impact factor: 8.410

9.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  The p53 functional circuit.

Authors:  S Jin; A J Levine
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  15 in total

Review 1.  Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis.

Authors:  Yu Lu; Yanqiong Liu; Jie Zeng; Yu He; Qiliu Peng; Yan Deng; Jian Wang; Li Xie; Taijie Li; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-02-01

2.  No association of the p53 codon 72 polymorphism with malaria in Ghanaian primiparae and Rwandan children.

Authors:  Prabhanjan P Gai; Stefanie Meese; George Bedu-Addo; Jean Bosco Gahutu; Frank P Mockenhaupt
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

Review 3.  Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.

Authors:  Mohammad Haroon Khan; Aftab Khalil; Hamid Rashid
Journal:  Genet Res (Camb)       Date:  2015-04-17       Impact factor: 1.588

4.  Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children.

Authors:  Hanaa Skhoun; Mohammed Khattab; Aziza Belkhayat; Zahra Takki Chebihi; Youssef Bakri; Nadia Dakka; Jamila El Baghdadi
Journal:  Mol Biol Rep       Date:  2022-06-15       Impact factor: 2.742

5.  Association of p53 and p21 polymorphisms with prostate cancer.

Authors:  Monika Kmeťová Sivoňová; Marta Vilčková; Ján Kliment; Silvia Mahmood; Jana Jurečeková; Svetlana Dušenková; Iveta Waczulíková; Peter Slezák; Dušan Dobrota
Journal:  Biomed Rep       Date:  2015-07-27

6.  Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes.

Authors:  Matthew A Kinseth; Zhenyu Jia; Farahnaz Rahmatpanah; Anne Sawyers; Manuel Sutton; Jessica Wang-Rodriguez; Dan Mercola; Kathleen L McGuire
Journal:  Int J Cancer       Date:  2013-07-13       Impact factor: 7.396

7.  Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Lifeng Zhang; Ning Shao; Qianqian Yu; Lixin Hua; Yuanyuan Mi; Ninghan Feng
Journal:  J Biomed Res       Date:  2011-01

8.  Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.

Authors:  Nicole A Lavender; Erica N Rogers; Susan Yeyeodu; James Rudd; Ting Hu; Jie Zhang; Guy N Brock; Kevin S Kimbro; Jason H Moore; David W Hein; La Creis R Kidd
Journal:  BMC Med Genomics       Date:  2012-04-30       Impact factor: 3.063

9.  MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.

Authors:  Li Xue; Xiujuan Han; Rongrong Liu; Ziming Wang; Hecheng Li; Qi Chen; Peng Zhang; Zhenlong Wang; Tie Chong
Journal:  Oncotarget       Date:  2016-05-31

10.  Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.

Authors:  Goar Mosoyan; Chandandeep Nagi; Svetlana Marukian; Avelino Teixeira; Anait Simonian; Lois Resnick-Silverman; Analisa DiFeo; Dean Johnston; Sandra R Reynolds; Daniel F Roses; Arevik Mosoian
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.